TP53 and breast cancer: Unlike the upregulation of telomerase, abnormalities in p53 are seen in only 20–40% of breast cancers, suggesting that disruption of p53 pathways may be of lesser importance in breast cancer pathogenesis (Mokbel et al, 2000; Borresen-Dale, 2003).